BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36257886)

  • 1. Preimplantation genetic testing for human blastocysts with potential parental contamination using a quantitative parental contamination test (qPCT): an evidence-based study.
    Dong Y; Liu D; Zou Y; Wan C; Chen C; Dong M; Huang Y; Huang C; Weng H; Zhu X; Wang F; Jiao S; Liu N; Lu S; Zhang X; Liu F
    Reprod Biomed Online; 2023 Jan; 46(1):69-79. PubMed ID: 36257886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preimplantation genetic testing for aneuploidies (abnormal number of chromosomes) in in vitro fertilisation.
    Cornelisse S; Zagers M; Kostova E; Fleischer K; van Wely M; Mastenbroek S
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD005291. PubMed ID: 32898291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing mosaicism: assessing the impact of fertilization method on rate of mosaicism after next-generation sequencing (NGS) preimplantation genetic testing for aneuploidy (PGT-A).
    Palmerola KL; Vitez SF; Amrane S; Fischer CP; Forman EJ
    J Assist Reprod Genet; 2019 Jan; 36(1):153-157. PubMed ID: 30362056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leave the past behind: women's reproductive history shows no association with blastocysts' euploidy and limited association with live birth rates after euploid embryo transfers.
    Cimadomo D; Capalbo A; Dovere L; Tacconi L; Soscia D; Giancani A; Scepi E; Maggiulli R; Vaiarelli A; Rienzi L; Ubaldi FM
    Hum Reprod; 2021 Mar; 36(4):929-940. PubMed ID: 33608730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormally fertilized oocytes can result in healthy live births: improved genetic technologies for preimplantation genetic testing can be used to rescue viable embryos in in vitro fertilization cycles.
    Capalbo A; Treff N; Cimadomo D; Tao X; Ferrero S; Vaiarelli A; Colamaria S; Maggiulli R; Orlando G; Scarica C; Scott R; Ubaldi FM; Rienzi L
    Fertil Steril; 2017 Dec; 108(6):1007-1015.e3. PubMed ID: 28923286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rationale for biopsying embryos reaching the morula stage on Day 6 in women undergoing preimplantation genetic testing for aneuploidy.
    Irani M; Zaninovic N; Canon C; O'Neill C; Gunnala V; Zhan Q; Palermo G; Reichman D; Rosenwaks Z
    Hum Reprod; 2018 May; 33(5):935-941. PubMed ID: 29546326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of preimplantation genetic testing for aneuploidy in IVF cycles for patients with advanced maternal age, repeat implantation failure, and idiopathic recurrent miscarriage.
    Lee CI; Wu CH; Pai YP; Chang YJ; Chen CI; Lee TH; Lee MS
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):239-243. PubMed ID: 30910146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide live births following the transfer of chromosomally "Abnormal" embryos after PGT/A: results of a worldwide web-based survey.
    Patrizio P; Shoham G; Shoham Z; Leong M; Barad DH; Gleicher N
    J Assist Reprod Genet; 2019 Aug; 36(8):1599-1607. PubMed ID: 31236830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of aneuploidy concordance between clinical trophectoderm biopsy and blastocyst.
    Victor AR; Griffin DK; Brake AJ; Tyndall JC; Murphy AE; Lepkowsky LT; Lal A; Zouves CG; Barnes FL; McCoy RC; Viotti M
    Hum Reprod; 2019 Jan; 34(1):181-192. PubMed ID: 30418565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First PGT-A using human in vivo blastocysts recovered by uterine lavage: comparison with matched IVF embryo controls†.
    Munné S; Nakajima ST; Najmabadi S; Sauer MV; Angle MJ; Rivas JL; Mendieta LV; Macaso TM; Sawarkar S; Nadal A; Choudhary K; Nezhat C; Carson SA; Buster JE
    Hum Reprod; 2020 Jan; 35(1):70-80. PubMed ID: 31886877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an artificial intelligence model for predicting the likelihood of human embryo euploidy based on blastocyst images from multiple imaging systems during IVF.
    Diakiw SM; Hall JMM; VerMilyea MD; Amin J; Aizpurua J; Giardini L; Briones YG; Lim AYX; Dakka MA; Nguyen TV; Perugini D; Perugini M
    Hum Reprod; 2022 Jul; 37(8):1746-1759. PubMed ID: 35674312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic diseases and aneuploidies can be detected with a single blastocyst biopsy: a successful clinical approach.
    Minasi MG; Fiorentino F; Ruberti A; Biricik A; Cursio E; Cotroneo E; Varricchio MT; Surdo M; Spinella F; Greco E
    Hum Reprod; 2017 Aug; 32(8):1770-1777. PubMed ID: 28633287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IVF outcomes of embryos with abnormal PGT-A biopsy previously refused transfer: a prospective cohort study.
    Barad DH; Albertini DF; Molinari E; Gleicher N
    Hum Reprod; 2022 May; 37(6):1194-1206. PubMed ID: 35413106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preimplantation genetic testing for aneuploidy in poor ovarian responders with four or fewer oocytes retrieved.
    Deng J; Hong HY; Zhao Q; Nadgauda A; Ashrafian S; Behr B; Lathi RB
    J Assist Reprod Genet; 2020 May; 37(5):1147-1154. PubMed ID: 32285297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the reproductive potential of day 7 euploid embryos?
    Hernandez-Nieto C; Lee JA; Slifkin R; Sandler B; Copperman AB; Flisser E
    Hum Reprod; 2019 Sep; 34(9):1697-1706. PubMed ID: 31398251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Gonadotropin Dosage Reduces Aneuploidy in Human Preimplantation Embryos: First Clinical Study in a UAE Population.
    Sachdeva K; Upadhyay D; Discutido R; Varghese MM; Albuz F; Almekosh R; Bouhafs L; Solkar S; Stevikova M; Peramo B
    Genet Test Mol Biomarkers; 2018 Oct; 22(10):630-634. PubMed ID: 30199281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inconclusive chromosomal assessment after blastocyst biopsy: prevalence, causative factors and outcomes after re-biopsy and re-vitrification. A multicenter experience.
    Cimadomo D; Rienzi L; Romanelli V; Alviggi E; Levi-Setti PE; Albani E; Dusi L; Papini L; Livi C; Benini F; Smeraldi A; Patassini C; Ubaldi FM; Capalbo A
    Hum Reprod; 2018 Oct; 33(10):1839-1846. PubMed ID: 30239718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pregnancy outcomes following preimplantation genetic testing for aneuploidy using a matched propensity score design.
    Haviland MJ; Murphy LA; Modest AM; Fox MP; Wise LA; Nillni YI; Sakkas D; Hacker MR
    Hum Reprod; 2020 Oct; 35(10):2356-2364. PubMed ID: 32856053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limits imposed by the experimental design of a large prospective non-inferiority study on PGT-A invalidate many of the conclusions.
    Scott RT; de Ziegler D; Pirtea P; Jalas C
    Hum Reprod; 2022 Nov; 37(12):2735-2742. PubMed ID: 36287636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016-2018.
    Sanders KD; Silvestri G; Gordon T; Griffin DK
    J Assist Reprod Genet; 2021 Dec; 38(12):3277-3285. PubMed ID: 34766235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.